EcoDrugPlus

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSOMYG00000013731
Gene Symbol: IGF1RA
1 Cross references
198 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSOMYG00000066583
Gene Symbol: IGF1RB
1 Cross references
202 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSOMYG00000059870
Gene Symbol: IGF1RB
1 Cross references
202 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSOMYG00000038418
Gene Symbol: ITGB3A
1 Cross references
195 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSOMYG00000014250
Gene Symbol: ITGB3A
1 Cross references
195 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOMYG00000032923
Gene Symbol: ITGA4
1 Cross references
219 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOMYG00000018259
Gene Symbol: ITGA4
2 Cross references
219 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOMYG00000047118
Gene Symbol: ITGB1
1 Cross references
223 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOMYG00000009591
Gene Symbol: ITGB1
1 Cross references
223 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOMYG00000015516
Gene Symbol: ITGB6
1 Cross references
203 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOMYG00000012738
Gene Symbol: ITGB6
1 Cross references
204 Possible Orthologues:

Integrin, Alpha 2b

Ensembl ID : ENSOMYG00000040536
Gene Symbol: ITGA2B
2 Cross references
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).